BTK and diffuse large B-cell lymphoma: However, the Bruton’s tyrosine kinase (BTK) inhibitors ibrutinib and acalabrutinib sensitized a subset of DLBCL cell lines to venetoclax across all five examined concentrations (Fig. 4a, b, Supplementary Fig. 3a, b).